Recurrent Clostridioides difficile infection can be treated with fecal microbiota transplants. FDA approval of Seres Therapeutics’ Vowst makes it the first oral microbiome therapy.
Seres’s Bacteria in a Pill Becomes First FDA-Approved Oral Microbiome Therapy
